PROPER Act of 2018

Bill: 115-hr-5775
Sponsor: Rep. Paulsen, Erik [R-MN-3]
Introduced: 2018-05-11 in the House
Policy area: Health
Subjects: Administrative law and regulatory procedures
Alternative treatments
Consumer affairs
Department of Health and Human Services
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Health care costs and insurance
Health care quality
Health information and medical records
Health personnel
Home and outpatient care
Hospital care
Medicare
Prescription drugs
Solid waste and recycling

Summary:
action_date: 2018-05-11
text: 

Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018

 
This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period). 
 
The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs. 
 
The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives. 

action_date: 2018-06-19
text: 

Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018

 
(Sec. 2) This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period). 
 
(Sec. 3) The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs. 
 
(Sec. 4) The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives. 


Legislative actions:
action_date: 2018-06-20
text: Received in the Senate and Read twice and referred to the Committee on Finance.
action_date: 2018-06-19
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2018-06-19
text: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)
action_date: 2018-06-19
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5256-5257)
action_date: 2018-06-19
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 5775.
action_date: 2018-06-19
text: Considered under suspension of the rules. (consideration: CR H5256-5258)
action_date: 2018-06-19
text: Mr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.
action_date: 2018-06-19
text: Placed on the Union Calendar, Calendar No. 594.
action_date: 2018-06-19
text: Committee on Energy and Commerce discharged.
action_date: 2018-06-19
text: Committee on Energy and Commerce discharged.
action_date: 2018-06-19
text: Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
action_date: 2018-06-19
text: Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
action_date: 2018-06-04
text: Referred to the Subcommittee on Health.
action_date: 2018-05-16
text: Ordered to be Reported (Amended) by Voice Vote.
action_date: 2018-05-16
text: Committee Consideration and Mark-up Session Held.
action_date: 2018-05-11
text: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2018-05-11
text: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2018-05-11
text: Introduced in House
action_date: 2018-05-11
text: Introduced in House